During the last session, CERo Therapeutics Holdings Inc (NASDAQ:CERO)’s traded shares were 0.32 million, with the beta value of the company hitting 0.39. At the end of the trading day, the stock’s price was $2.06, reflecting an intraday gain of 14.44% or $0.26. The 52-week high for the CERO share is $1238.00, that puts it down -59997.09 from that peak though still a striking 17.48% gain since the share price plummeted to a 52-week low of $1.70. The company’s market capitalization is $6.24M, and the average intraday trading volume over the past 10 days was 0.28 million shares, and the average trade volume was 836.27K shares over the past three months.

CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information

CERo Therapeutics Holdings Inc (CERO) registered a 14.44% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 14.44% in intraday trading to $2.06, hitting a weekly high. The stock’s 5-day price performance is 6.19%, and it has moved by -20.16% in 30 days. Based on these gigs, the overall price performance for the year is -99.63%. The short interest in CERo Therapeutics Holdings Inc (NASDAQ:CERO) is 0.57 million shares and it means that shorts have 0.45 day(s) to cover.

CERO Dividends

CERo Therapeutics Holdings Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Data provided on Nov 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 1.43 shares. This amounts to just over 0.05 percent of the company’s overall shares, with a $2949.0 market value.